First time ultra-sensitive and simultaneous quantification of proteins, interact...
First time ultra-sensitive and simultaneous quantification of proteins, interactions, and post-translational modifications in single cells to enable exponential growth in proteomics and inte
In a human cell there are about 20k protein coding genes (genome) that originate ~100k proteins (proteome). Proteins are involved in complex networks of protein-protein interactions (PPIs) influenced by post-translational modifica...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
EIN2019-103460
NUEVAS ESTRATEGIAS DE CONTROL DE HONGOS BASADAS EN EL DISEÑO...
12K€
Cerrado
nbPTMs
A multifaceted platform for exploring nucleotide based post...
2M€
Cerrado
ProteaseNter
Disseminating N terminomics to Advance Protease Research
150K€
Cerrado
EQC2021-007086-P
Plataforma de proteómica estructural basada en espectrometrí...
800K€
Cerrado
PTA2020-019567-I
HIGH-THROUGHPUT IDENTIFICATION OF NOVEL BIOMARKERS AND MOLEC...
42K€
Cerrado
Duración del proyecto: 27 meses
Fecha Inicio: 2023-04-11
Fecha Fin: 2025-07-31
Líder del proyecto
ACTOME GMBH
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
4M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
In a human cell there are about 20k protein coding genes (genome) that originate ~100k proteins (proteome). Proteins are involved in complex networks of protein-protein interactions (PPIs) influenced by post-translational modifications (PTMs), the interactome of living cells (~800,000 entities). The genome is mostly static throughout cell lifetime and can be sequenced today in <1h. The proteome and interactome are changing with e.g., environment and health, and not yet fully known. Today's methods for proteomics and interactomics are tedious, and lack sensitivity, quantitativity and parallelism.
PICO-NGS combines ultra-high sensitivity (>10 fM) with high parallelism measuring proteins, PPIs, and PTMs simultaneously (>50 targets). This will disrupt the global proteomics market (€29 B worth, 16% CAGR). This will fertilise ground-breaking academic research and accelerate developments in e.g., Pharma (drug discovery), Biotech (biomarkers/diagnosis), and Agrotech (crop sciences) industries.